Insulet (PODD) Acquisitions (2022 - 2023)
Insulet (PODD) reported Acquisitions of $3.0 million for Q1 2023, down 88.46% on a YoY basis from $26.0 million in Q1 2022, and down 88.46% quarter-over-quarter from $26.0 million in Q1 2022.
Insulet (PODD) Acquisitions (2022 - 2023) Analysis & Trends
Insulet has reported Acquisitions for 2 years, with the latest figure at $3.0 million in Q1 2023.
- For the quarter ending Q1 2023, Acquisitions fell 88.46% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2023 stood at $3.0 million (down 88.46% YoY), and the FY2023 full-year result was $3.0 million, down 88.46% from the prior year.
- Acquisitions for Q1 2023 stood at $3.0 million, down from $26.0 million in the prior quarter.
- The five-year high for Acquisitions was $26.0 million in Q1 2022, with the low at $3.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.47 Bn | 9.99 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.00 Mn |
| Mar 31, 2022 | 26.00 Mn |